トルコで最高のリンパ管腫医師 - トップ22名の医師

ブルント・カラゲズ博士は、トルコのトップ医療腫瘍学者であり、肉腫、リンパ腫、膵臓、肺がんの専門家であり、乳がん外科の医師で、20年以上の経験を持ちます。彼の主なサブスペシャリティは、腫瘍生物学、腫瘍免疫学、がん免疫療法、標的療法です。

職務経験

• 2019年から — アナドル医療センターの医療腫瘍学者
• 2019年 — イスタンブールオカン大学医学部の内科部長、内科および医療腫瘍学部門の部門長および医学倫理委員会の委員長
• 2017-2019年 — GATA ハイダルパシャトレーニング病院の内科の医療腫瘍学部門の部門長
• 2012-2017年 — GATA ハイダルパシャトレーニング病院の内科の医療腫瘍学部セクションの責任者
• 2003年 — チョルル兵士病院の内科医
• 2001年 — NATO の NATO KFOR コマンド
• 1993-1995年 — トルコ系キプロス和平部隊の司令部。

教育

• 1992年 — ギュルハネ軍医科大学 — 一般医学の学位
• 1999年 — GATA ハイダルパシャトレーニング病院 — 内科の専門
• 2006年 — GATA ハイダルパシャトレーニング病院 — 医療腫瘍学の専門。

教育活動

• 2017年 — イスタンブールオカン大学医学部の教授。

科学活動

がん研究で40を超える出版物を執筆しています。

会員資格

• トルコ医療腫瘍学協会

ヨーロッパ頭頸部協会

コース参加

• 腫瘍生物学コース、医療腫瘍学協会、2003年。
• フローサイトメトリートレーニング、イスタンブール大学 (DETAE)、2004年。
• 基本的な疫学（健康における研究手法と分析技術）コース、GATA コマンド、2005年。
• 臨床研究における倫理的アプローチコース、厚生労働省医薬品局および薬局の総局、2009年および2017年（2回）。

ムスタファ・ソラク博士は、ヒサール・ホスピタル・インターコンチネンタルにおいて乳癌、肺癌、消化器癌を専門とし、ハジェテペ大学およびMDアンダーソン癌センターにて研修を修了しています。

• 腫瘍外科フェローシップ修了
• 頭頸部癌治療における豊富な経験
• MDアンダーソン癌センターをはじめとする一流医療機関での勤務経験
• 低侵襲腫瘍治療処置を専門とする

Prof. Hüseyin Baloğlu is a pathology specialist at Anadolu Medical Center in Gebze, Kocaeli, Turkey. He focuses on molecular pathology, surgical pathology, and tumour biopsy and diagnostics.

Education and accreditations: MD, GATA Medical School (1986). Pathology specialty training, GATA (1992). Associate Professor (Doçent), GATA (2004). Visiting scholar at Albert Einstein College of Medicine (New York) and Heidelberg University.

Achievements: author of over 600 peer‑reviewed publications. Holds a patent in molecular diagnostics for thyroid cancer. Leads liquid biopsy and precision oncology services.

Personal Information 

Sex:  Male

Born : 1968 

Professional Experience

Gayrettepe Florence Nigthingale Hospital

Medical Oncology Department

Besiktas/Istanbul/Turkey (ongoing)

Education:

He became Professor (22/April /2016)

Medical Oncology

Attending Phys.in Gastrointestinal Oncology (January 2005 ,2009)

Istanbul University Oncology Institue,

Department of Medical Oncology

Medical Oncology Fellowship (December 2001-December2004)

Istanbul University, Istanbul Medical Faculty

Hemodialysis Traning (May1996-January1997)

Istanbul University ,bCerrahpasa Medical Faculty

Internal Medicine Residency (November 1991-November 1996)

Istanbul University ,bCerrahpasa Medical Faculty

Ege University Medical Faculty (1985-1991)

Professional Experience

February 1999-November 2001

Metropolitan Florence Nigthingale Hospital

American Cancer Center, Gayrettepe/İstanbul

April1997- October 1998

Bayraktar Dialysis Center

Güngören/ Istanbul

Membership

Turkish Medical Oncology Association

ENET(European Neuroendocrine Tumour Society)

ESMO

ASCO

Prof. Dr. Sezer Sağlam is a medical oncologist at Gayrettepe Florence Nightingale Hospital. He specializes in gastrointestinal and breast cancers. He has contributed to cancer care through research, especially with his study on the best timing for surgery after neoadjuvant therapy in rectal cancer. This work has influenced global treatment protocols.

Dr. Sağlam has led clinical trials in targeted therapies and precision medicine. His research on liver-transplanted patients with hepatocellular carcinoma was nominated for the 2024 International Best Researcher Award. He is a member of ASCO, ESMO, and ENET. Dr. Sağlam provides personalized and evidence-based oncology care.

Education and Expertise

Selcuk University Meram Faculty of Medicine - Medical Education

Dr.Abdurrahman Yurtaslan Anakara Oncology Training and Research Hospital Medical Oncology Specialization

Experience

Malatya State Hospital Internal Diseases Clinic

Ankara Oncology Hospital Medical Oncology Clinic

Erzurum Regional Training and Research Hospital Medical Oncology Clinic


AREAS OF INTEREST

Lung cancer

esophageal cancer

Gastric cancer

breast cancer

Gastrointestinal surgery

https://scholar.google.com.tr/citations?user=EDuylhoAAAAJ&hl=tr 

Associate Professor Dr. Yusuf AÇIKGÖZ
Specialization: Medical Oncology

Education:

• 2004-2011: İnönü University Faculty of Medicine
• 2011-2016: Ankara Numune Training and Research Hospital, Internal Medicine
• 2017-2022: Health Sciences University, Medical Oncology

Professional Experience:

• 2016-2017: Bingöl City Hospital, Internal Medicine
• 2021-2022: Health Sciences University, Medical Oncology
• 2022-2023: Kastamonu Education and Research Hospital, Medical Oncology
• 2023-2024: Ohio State University, Medical Oncology
• 2024-Present: Lokman Hekim University, Medical Oncology, Ankara Hospital

Clinical Trials, Courses, Certifications:

Clinical Trials:

• 2017-2021: Phase III, CheckMate-649 Study (Assistant Investigator)
• 2022-Present: Phase III, Fortitude-101 Study (Assistant Investigator)

Courses:

• 2018: Medicres Basic and Advanced Biostatistics Training Program (ongoing), Istanbul-Vienna
• 2019: Immuno-Oncology Education Course, March 1-2, 2019, Vienna, Central European Cooperative Oncology Group (CECOG)
• 2018: Good Clinical Practice Certification, April 7-8, 2018, Ankara, Health Sciences University
• 2017: Basic Oncology Training Program, November 25-26, 2017, Adana, Clinical Oncology Society
• 2016: Basic Ultrasonography Course (10 hours theoretical + 10 hours practical), September 24-25, 2016, Ankara, Turkish Emergency Medicine Association

Certifications:

• Ongoing: ECFMG Certification
• 2024: CITI Responsible Conduct of Research (The Ohio State University)
• 2024: CITI IACUC-Laboratory Animal Research (The Ohio State University)
• 2024: CITI Human Subjects Protection (The Ohio State University)
• 2024: CITI Good Clinical Practice (The Ohio State University)
• 2023: Occupational English Test (OET)
• 2019: International English Language Testing System (IELTS), Total Score: 6.5, May 26, 2019, Ankara, British Council
• 2017: USMLE Step 2 CK Exam; Score: 244, February 7, 2017
• 2016: USMLE Step 1 Exam; Score: 215, August 25, 2016

Memberships:

• American Society of Clinical Oncology (ASCO) - 2022
• Turkish Society of Medical Oncology - 2020

Assoc. Prof. Atakan Topçu, M.D., is a medical oncologist at Medipol University and Medipol Acıbadem Regional Hospital. He treats solid tumors, including lung, breast, colorectal, gastric, and neuroendocrine cancers. His work also covers targeted therapies, immunotherapy, geriatric oncology, and cancer-related malnutrition, cachexia, and sarcopenia.

He has authored more than 50 peer-reviewed papers. Recent work includes a 2024 Frontiers in Medicine study on geriatric syndromes and a 2023 Future Oncology paper on sarcopenia and anxiety in lung cancer. He has also published on the CONUT score in breast cancer and on malnutrition in HER2-negative metastatic gastric cancer.

Dr. Topçu serves on the Editorial Board of BMC Cancer. He is a member of the Turkish Society of Medical Oncology, ESMO, and the Turkish Geriatrics Society. Education and training: M.D., Uludağ University; residency in Internal Medicine, Marmara University; fellowship in Medical Oncology, Bezmialem Vakıf University.

Education and Specialization

• 2006: Kocaeli University Faculty of Medicine
• 2014: Akdeniz University Faculty of Medicine, Internal Medicine
• 2018: Akdeniz University Faculty of Medicine, Medical Oncology

Experience

• 2006 - 2008: Konya Derebucak District Hospital
• 2009 - 2015: Akdeniz University Hospital
• 2015: Antalya Kaş State Hospital
• 2015 - 2016: İnönü University Faculty of Medicine
• 2016 - 2021: Akdeniz University Hospital
• 2021 - 2023: Antalya Training and Research Hospital

Dr. Irfan Cicin is a Professor of Medical Oncology at the Trakya University Faculty of Medicine (2015–present). He has over 20 years of medical oncology experience and has held academic roles since 2010.

Education: MD, Istanbul University – Cerrahpaşa (1991–1997). Residency in Internal Medicine, Trakya University (1997–2002). Fellowship in Medical Oncology, Trakya University (2002–2004).

Practice: Medical Oncologist, Trakya University (2005–2008). Medical Oncologist, Elazığ Training and Research Hospital (2008–2010). Associate Professor of Medical Oncology, Trakya University (2010–2015). He previously served as a physician in the Turkish Air Force at Etimesgut Military Hospital (2004–2005).

Dr. Muhammed Mustafa Atci is an Associate Professor of Medical Oncology at İstinye University, Liv Hospital Topkapı (2025–present). He previously served as Associate Professor and Education Coordinator at Prof. Dr. Cemil Taşcıoğlu City Hospital (2023–2025). He was also a Medical Oncologist there (2018–2021).

He has been a member of ASCO and the Turkish Society of Medical Oncology since 2018. He is the author or co-author of 19 peer-reviewed international papers on colon, breast, gastric, pancreatic, lung, thyroid, sarcoma, and colorectal cancers.

Notable works include a multicentre study on stage IIB colon cancer survival (Journal of Chemotherapy). He also studied the De Ritis ratio for lung metastasis in testicular cancer (Current Urology). His prognostic studies used PET/CT, MSI, lymph node ratio, and metabolic tumor volume.

Education

Cumhuriyet University Faculty of Medicine, 2004
Istanbul Haydarpaşa Training and Research Hospital Internal Medicine Residency, 2010
Karadeniz Technical University Faculty of Medicine Medical Oncology Residency, 2015

Experience

MD Andeson Cancer Center, USA, 2008
Sunnybrook Odette Cancer Center Breast Cancer Clinic, Canada, 2017
Moffit Cancer Center , USA 2022
Istanbul Haydarpaşa Training and Research Hospital Internal Medicine, 2010
İdil State Hospital Internal Medicine Clinic, 2011
Karadeniz Technical Universityniversitesi Faculty of Medicine, Medical Oncology Clinic, 2015
Istanbul Göztepe Training and Research Hospital, Medical Oncology Clinic, 2018
Yeniyüzyıl University Gaziosmanpaşa Hospital, Medical Oncology Clinic, 2020
Ataşehir Medicana Hospital, Medical Oncology Clinic, 2022

Scientific Membership

Turkish Medical Association (TTB)
Turkish Society of Medical Oncology (TTOD)
European Society for Medical Oncology (ESMO)
American Society of Medical Oncology (ASCO)

Medical Intrests

• Breast Cancer
• Lung Cancer
• Colon Cancer
• Stomach Cancer
• Rectal Cancer
• Ovarian Cancer
• Liver Cancer
• Oesophageal Cancer - Oesophageal Cancer
• Kidney Cancer
• Larynx Cancer - Cancer of the Larynx
• Thyroid Cancer
• Head and Neck Cancers
• Gynaecological Cancers
• Pancreatic Cancer
• Oesophageal Cancer - Oesophageal Cancer
• Uterine Cancer
• Brain Cancers - Brain Tumours
• Soft Tissue Cancer - Sarcomas
• Prostate Cancer
• Bladder Cancer
• Bile Tract Cancer
• Testicular Cancer
• Cervical Cancer
• Mouth, Tongue, Lip Cancers
• Gastrointestinal System Cancers
• Bone Tumours
• Trachea and Bronchial Cancers
• Skin Cancers - Skin Cancers
• Skeletal System Tumours
• Gallbladder Cancer
• Mesothelioma

Marmara University Faculty of Medicine, Department of Radiation Oncology Specialization training: 2012 -2016

Marmara University Faculty of Medicine (English) Undergraduate: 2004-2011

Sixteen Numbered Shirvan School (Azerbaijan) High School: 1998 -2004

教育経験

• アメリカン・ロバート・カレッジ、イスタンブル、トルコ (1973-1977)
• ウルダ大学医学部、医学のディプロマ、ブルサ、トルコ (1983)
• 国立がん研究所、N.C.I、N.I.H 研究奨学金、「職業曝露とがんリスク」 ベセスダ、MD、米国 (1989)
• オンコロジー・核医学センター、 放射線腫瘍学研修医、イスタンブル、トルコ 専門認定証 (1990)
• トーマス・ジェファーソン大学、博士後研究フェローシップ、サーモラジオセラピー学部放射線腫瘍学科 フィラデルフィア、PA、米国 (1990-1994)

経験

• パザルヨル・メディカル・ハウス、義務奉仕 イスピル、エルズルム、トルコ (1985-1986)
• 国立がん研究所、N.C.I、N.I.H 研究奨学金「職業曝露とがんリスク」 ベセスダ、MD、米国 (1989)
• オンコロジー・核医学センター、放射線腫瘍学研修医 イスタンブル、トルコ 専門認定証 (1990)
• トーマス・ジェファーソン大学、博士後研究フェローシップ サーモラジオセラピー学部放射線腫瘍学科 フィラデルフィア、PA、米国 (1990-1994)
• ウルダ大学医学部 (1991-2005) 教授 (1999-2005) & 学部長 (1994-2005) 放射線腫瘍学科 ブルサ、トルコ
• ウルダ大学医学部、学部認定コーディネーター ブルサ、トルコ (2001-2004)
• アナドルメディカルセンター、教授 & 放射線腫瘍学科長 イスタンブル、トルコ (2004-2017)
• アナドルメディカルセンター、腫瘍科学コーディネーター イスタンブル、トルコ (2011-2017)
• ジェイラン国際病院、腫瘍科学ディレクター ブルサ、トルコ (2017-2018)
• メディカナ・ブルサ病院、腫瘍科学ディレクター ブルサ、トルコ (2018-現在)

Assoc. Dr. Ugur Ekici is a renowned General Surgeon with more than 20 years of experience, specialising in Obesity and Metabolic Surgery, Advanced Laparoscopic Surgery, Thyroid and Parathyroid Surgery, Cancer Surgery and more.

• Faculty of Medicine from the Erciyes University in 2000
• Specialty training from Şişli Etfal Hospital General Surgery Clinic in 2009
• Articles published in international refereed journals
• Special interest in Obesity and Metabolic Surgery, Advanced Laparoscopic Surgery, Thyroid and Parathyroid Surgery, Cancer Surgery and more.